Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

Laura C Coates, Toby Garrood, Nicola Gullick, Philip Helliwell, Toby Kent, Jonathan Marks, William Tillett, Daljit Kaur-Papadakis, Hasan Tahir, Stijn van Haaren, Iain McInnes

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article numberkeac388
JournalRheumatology (Oxford, England)
Early online date7 Jul 2022
Publication statusE-pub ahead of print - 7 Jul 2022

Cite this